This Week in JAMA

Premium

In JAMA this week, researchers in the US and Sweden assess cancer risk among patients with myotonic muscular dystrophy, autosomal-dominant multisystem neuromuscular disorder. Previous case reports have suggested that patients with this type of dystrophy, which is characterized by unstable nucleotide repeat expansions, may be at increased risk for malignancies. For this study, the researchers analyzed data from 1,658 MMD patients, and found that 104 developed cancer following their MMD diagnosis.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.